Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. CVS Health stock is way up but still ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

HARTFORD— This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. CVS' reputation in Connecticut ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

CVS Health posted stronger-than-expected fourth quarter earnings Wednesday, including a narrowing of its key benefit-expense ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...